Rhodiola rosea: A Therapeutic Candidate on Cardiovascular Diseases | Zendy

Yingqing Chen | Zendy; Minli Tang | Zendy; Shuo Yuan | Zendy; Shuang Fu | Zendy; Yifei Li | Zendy; You Li | Zendy; Qi Wang | Zendy; Yuying Cao | Zendy; Liping Liu | Zendy; Qinggao Zhang | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Rhodiola rosea: A Therapeutic Candidate on Cardiovascular Diseases

Author(s) -

Yingqing Chen,

Minli Tang,

Shuo Yuan,

Shuang Fu,

Yifei Li,

You Li,

Qi Wang,

Yuying Cao,

Liping Liu,

Qinggao Zhang

Publication year - 2022

Publication title -

oxidative medicine and cellular longevity

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.494

H-Index - 93

eISSN - 1942-0900

pISSN - 1942-0994

DOI - 10.1155/2022/1348795

Subject(s) - rhodiola rosea , medicine , hyperlipidemia , salidroside , disease , etiology , rhodiola , traditional medicine , pharmacology , diabetes mellitus , endocrinology

Cardiovascular diseases, also known as circulatory diseases, are diseases of the heart and blood vessels, and its etiology is hyperlipidemia, thick blood, atherosclerosis, and hypertension. Due to its high prevalence, disability, and mortality, it seriously threatens human health. According to reports, the incidence of cardiovascular disease is still on the rise. Rhodiola rosea is a kind of traditional Chinese medicine, which has the effects of antimyocardial ischemia-reperfusion injury, lowering blood fat, antithrombosis, and antiarrhythmia. Rhodiola rosea has various chemical components, and different chemical elements have the same pharmacological effects and medicinal values for various cardiovascular diseases. This article reviews the research on the pharmacological effects of Rhodiola rosea on cardiovascular diseases and provides references for the clinical treatment of cardiovascular diseases.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research